Long-Term Assessment of Topiramate for Epilepsy: An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting

By Hufnagel Andreas  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 779-790

Adis International

Access to resources Recommend Favorite

Efficacy of Topiramate in Adult Patients with Symptomatic Epilepsy: An Open-Label, Long-Term, Retrospective Observation

By Lu Yang  

CNS Drugs, Vol. 23, Iss. 4, 2009-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Lacosamide in the Concomitant Treatment of 130 Patients Under 16 Years of Age with Refractory Epilepsy: A Prospective, Open-Label, Observational, Multicenter Study in Spain

By Casas-Fernández Carlos  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 187-197

Adis International

Access to resources Recommend Favorite

Long-Term Efficacy and Tolerability of a Fixed-Dose Combination of Antihypertensive Agents: An Open-Label Surveillance Study in China

By Wu Yiqun   Hu Yonghua   Tang Xun   He Liu   Ren Tao   Tao Qiushan   Qin Xueying   Sun Ningling  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 769-777

Adis International

Access to resources Recommend Favorite